ITGR logo

Integer Holdings Corporation Stock Price

NYSE:ITGR Community·US$4.3b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author

ITGR Share Price Performance

US$125.26
19.72 (18.68%)
US$112.14
Fair Value
US$125.26
19.72 (18.68%)
11.7% overvalued intrinsic discount
US$112.14
Fair Value
Price US$125.26
AnalystConsensusTarget US$112.14
AnalystLowTarget US$95.00

ITGR Community Narratives

·
Fair Value US$112.14 11.7% overvalued intrinsic discount

ITGR: Shares Will Recover As Demand Normalizes And Inventory Pressures Ease

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value US$95 31.9% overvalued intrinsic discount

Electrophysiology Inventory Rebalancing And High Leverage Will Pressure Margins For Years

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$112.14
11.7% overvalued intrinsic discount
Revenue
3.87% p.a.
Profit Margin
8.12%
Future PE
25.07x
Price in 2029
US$136.89

Trending Discussion

No trending discussion available.

Updated Narratives

ITGR logo

Electrophysiology Inventory Rebalancing And High Leverage Will Pressure Margins For Years

Fair Value: US$95 31.9% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ITGR logo

ITGR: KKR Buyout Price Will Cap Upside And Drive 2026 Outlook

Fair Value: US$112.14 11.7% overvalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Solid track record and fair value.

1 Risk
3 Rewards

Integer Holdings Corporation Key Details

US$1.8b

Revenue

US$1.4b

Cost of Revenue

US$481.7m

Gross Profit

US$353.3m

Other Expenses

US$128.4m

Earnings

Last Reported Earnings
Jul 03, 2026
Next Reporting Earnings
n/a
3.78
26.13%
6.97%
72.0%
View Full Analysis

About ITGR

Founded
1970
Employees
11000
CEO
Payman Khales
WebsiteView website
www.integer.net

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Recent ITGR News & Updates

New Narrative Aug 04

Electrophysiology Inventory Rebalancing And High Leverage Will Pressure Margins For Years

Catalysts About Integer Holdings Integer Holdings is a medical device contract manufacturer that supplies cardio and vascular, electrophysiology, cardiac rhythm management and neuromodulation products to large OEMs and emerging companies. What are the underlying business or industry changes driving this perspective?
Narrative Update Aug 04

ITGR: KKR Buyout Price Will Cap Upside And Drive 2026 Outlook

The updated analyst price target for Integer Holdings now sits at $112.14, up from $97.56. Analysts point to modest adjustments in revenue growth assumptions, a slightly lower discount rate, and a higher future P/E multiple as key drivers of the change.

Recent updates

No updates